IS7245A - Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja - Google Patents
Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfjaInfo
- Publication number
- IS7245A IS7245A IS7245A IS7245A IS7245A IS 7245 A IS7245 A IS 7245A IS 7245 A IS7245 A IS 7245A IS 7245 A IS7245 A IS 7245A IS 7245 A IS7245 A IS 7245A
- Authority
- IS
- Iceland
- Prior art keywords
- lithiums
- pharmaceuticals
- reacting
- manufacture
- reaction products
- Prior art date
Links
- 239000007795 chemical reaction product Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G5/00—Alkaloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH02094/01A CH695417A5 (de) | 2001-11-15 | 2001-11-15 | Verfahren zur Umsetzung von Alkaloiden. |
| PCT/EP2002/012003 WO2003041721A1 (en) | 2001-11-15 | 2002-10-28 | Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS7245A true IS7245A (is) | 2004-04-30 |
| IS2812B IS2812B (is) | 2012-11-15 |
Family
ID=4567486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7245A IS2812B (is) | 2001-11-15 | 2004-04-30 | Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US20050043340A1 (is) |
| EP (1) | EP1443943B1 (is) |
| JP (1) | JP2005509006A (is) |
| KR (1) | KR100849488B1 (is) |
| CN (1) | CN100436462C (is) |
| AR (1) | AR037527A1 (is) |
| AT (1) | ATE485826T1 (is) |
| AU (1) | AU2002346888B2 (is) |
| BR (1) | BR0214173A (is) |
| CA (1) | CA2465723C (is) |
| CH (1) | CH695417A5 (is) |
| CO (1) | CO5580784A2 (is) |
| CR (1) | CR7340A (is) |
| CU (1) | CU23451B7 (is) |
| CY (1) | CY1111139T1 (is) |
| DE (1) | DE60238134D1 (is) |
| DK (1) | DK1443943T3 (is) |
| EA (1) | EA007097B1 (is) |
| EC (1) | ECSP045107A (is) |
| ES (1) | ES2353207T3 (is) |
| GE (1) | GEP20053701B (is) |
| HK (1) | HK1054041A1 (is) |
| HR (1) | HRP20040430A2 (is) |
| HU (1) | HU229688B1 (is) |
| IL (2) | IL161766A0 (is) |
| IS (1) | IS2812B (is) |
| MA (1) | MA26232A1 (is) |
| MX (1) | MXPA04004643A (is) |
| NO (1) | NO334701B1 (is) |
| NZ (1) | NZ532941A (is) |
| PL (1) | PL212111B1 (is) |
| PT (1) | PT1443943E (is) |
| RS (1) | RS51219B (is) |
| SA (1) | SA02230496B1 (is) |
| TN (1) | TNSN04084A1 (is) |
| TW (1) | TWI262080B (is) |
| UA (1) | UA76535C2 (is) |
| WO (1) | WO2003041721A1 (is) |
| ZA (1) | ZA200403371B (is) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1459753A1 (en) | 2003-03-18 | 2004-09-22 | Nowicky, Wassyl, Dipl.-Ing. DDr. | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
| WO2006053649A1 (en) * | 2004-11-19 | 2006-05-26 | Nowicky Wassili | Method for the detection of cancer |
| WO2006053680A1 (en) * | 2004-11-19 | 2006-05-26 | Nowicky Wassili | Ex vivo cancer diagnostic method |
| WO2007073919A2 (en) | 2005-12-28 | 2007-07-05 | Nowicky Wassili | Method and kit for the detection of cancer |
| ITMI20080284A1 (it) * | 2008-02-22 | 2009-08-23 | Indena Spa | Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono |
| CA2941315C (en) * | 2016-08-12 | 2018-03-06 | Api Labs Inc. | High thebaine poppy and methods of producing the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU368254A1 (ru) * | 1969-06-16 | 1973-01-26 | А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт | Способ получения соединений тиофосфамида с алкалоидами чистотела большого |
| US3865830A (en) * | 1969-06-16 | 1975-02-11 | Nikolai Mikhailovich Turkevich | Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof |
| AT354644B (de) * | 1975-12-19 | 1980-01-25 | Nowicky Wassili | Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure |
| AT377988B (de) * | 1976-06-28 | 1985-05-28 | Nowicky Wassili | Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden |
| DE3128018A1 (de) * | 1981-07-13 | 1983-04-07 | Wassyl 1060 Wien Nowicky | "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze" |
| US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
| AT407608B (de) * | 1994-03-18 | 2001-05-25 | Nowicky Wassili | Mittel zur behandlung von osteoporose |
| AT407833B (de) * | 1995-06-01 | 2001-06-25 | Nowicky Wassyl Dr | Mittel zur behandlung von strahlenschäden |
| AT408719B (de) * | 2000-03-22 | 2002-02-25 | Nowicky Wassili | Mittel zur behandlung von hepatitis c |
-
2001
- 2001-11-15 CH CH02094/01A patent/CH695417A5/de not_active IP Right Cessation
-
2002
- 2002-10-25 TW TW091125317A patent/TWI262080B/zh not_active IP Right Cessation
- 2002-10-28 EA EA200400679A patent/EA007097B1/ru not_active IP Right Cessation
- 2002-10-28 PT PT02783017T patent/PT1443943E/pt unknown
- 2002-10-28 AT AT02783017T patent/ATE485826T1/de active
- 2002-10-28 JP JP2003543608A patent/JP2005509006A/ja active Pending
- 2002-10-28 ES ES02783017T patent/ES2353207T3/es not_active Expired - Lifetime
- 2002-10-28 BR BR0214173-6A patent/BR0214173A/pt not_active IP Right Cessation
- 2002-10-28 UA UA20040604558A patent/UA76535C2/uk unknown
- 2002-10-28 MX MXPA04004643A patent/MXPA04004643A/es active IP Right Grant
- 2002-10-28 IL IL16176602A patent/IL161766A0/xx unknown
- 2002-10-28 EP EP02783017A patent/EP1443943B1/en not_active Expired - Lifetime
- 2002-10-28 DK DK02783017.3T patent/DK1443943T3/da active
- 2002-10-28 RS YUP-408/04A patent/RS51219B/sr unknown
- 2002-10-28 DE DE60238134T patent/DE60238134D1/de not_active Expired - Lifetime
- 2002-10-28 CA CA002465723A patent/CA2465723C/en not_active Expired - Fee Related
- 2002-10-28 KR KR1020047007480A patent/KR100849488B1/ko not_active IP Right Cessation
- 2002-10-28 GE GE8206A patent/GEP20053701B/en unknown
- 2002-10-28 AU AU2002346888A patent/AU2002346888B2/en not_active Ceased
- 2002-10-28 WO PCT/EP2002/012003 patent/WO2003041721A1/en active IP Right Grant
- 2002-10-28 PL PL368879A patent/PL212111B1/pl unknown
- 2002-10-28 HU HU0402365A patent/HU229688B1/hu unknown
- 2002-10-28 US US10/495,729 patent/US20050043340A1/en not_active Abandoned
- 2002-10-28 NZ NZ532941A patent/NZ532941A/en not_active IP Right Cessation
- 2002-11-15 AR ARP020104397A patent/AR037527A1/es unknown
- 2002-11-15 CN CNB021513384A patent/CN100436462C/zh not_active Expired - Fee Related
- 2002-12-30 SA SA02230496A patent/SA02230496B1/ar unknown
-
2003
- 2003-08-29 HK HK03106188.6A patent/HK1054041A1/xx not_active IP Right Cessation
-
2004
- 2004-04-30 IS IS7245A patent/IS2812B/is unknown
- 2004-05-04 IL IL161766A patent/IL161766A/en not_active IP Right Cessation
- 2004-05-04 ZA ZA200403371A patent/ZA200403371B/en unknown
- 2004-05-05 NO NO20041845A patent/NO334701B1/no not_active IP Right Cessation
- 2004-05-11 CR CR7340A patent/CR7340A/es unknown
- 2004-05-13 TN TNP2004000084A patent/TNSN04084A1/en unknown
- 2004-05-14 HR HR20040430A patent/HRP20040430A2/hr not_active IP Right Cessation
- 2004-05-14 EC EC2004005107A patent/ECSP045107A/es unknown
- 2004-05-14 MA MA27679A patent/MA26232A1/fr unknown
- 2004-05-17 CU CU20040105A patent/CU23451B7/es not_active IP Right Cessation
- 2004-06-01 CO CO04051024A patent/CO5580784A2/es not_active Application Discontinuation
-
2011
- 2011-01-24 CY CY20111100077T patent/CY1111139T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20031776D0 (no) | Null-boringskomplettering og produksjonssystem | |
| DK1436309T3 (da) | BGL3-beta-glukosidase og nukleinsyrer kodende derfor | |
| NO20052860D0 (no) | Farmasoytiske pelletter omfattende tamsulosin og en fremgangsmate for fremstilling av samme | |
| DK1511790T3 (da) | Polyaminosyrer funktionaliseret med alfa-tocopherol og anvendelser deraf, især til terapeutiske applikationer | |
| IS7369A (is) | Aðferð og tæki til örflögunýmyndunar | |
| IS2513B (is) | Búnaður til að framleiða óson og aðferð til framleiðslu á ósoni | |
| IS7090A (is) | Kerfi,aðferð og tölvuhugbúnaður til að forma og kaupa lækningatæki | |
| DK2423335T3 (da) | Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf | |
| NO20033587D0 (no) | Fremgangsmåte og innretning for fremstilling av mineralull og produkter derav | |
| NO20034079D0 (no) | Fremgangsmåte for fremstilling av interpolymerer og produkter laget derav | |
| DK1206495T3 (da) | Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf | |
| DK1641822T3 (da) | Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf. | |
| NO20040894L (no) | Fremgangsmate for fremstilling av klorsyrling og klordioksid | |
| IS6724A (is) | Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra | |
| DK1516053T3 (da) | Xylanaser, nucleinsyrer, som koder herfor, og fremgangsmåder til at fremstille og benytte disse | |
| NO20052410D0 (no) | Vannloselige jernkarbobydratkomplekser, produksjon derav og medikamenter inneholdende disse komplekser | |
| NO20031775D0 (no) | Oppblåsbar pakning og fremgangsmåte | |
| NO20035310D0 (no) | Kjemisk reaksjonsinnretning og kraftforsyningssystem | |
| IS7594A (is) | Laxófoxifen tafla og húðun hennar | |
| NO20053244D0 (no) | Katalytisk reaktor og fremgangsmate. | |
| DK1281721T3 (da) | Termisk konverterede stivelser og fremgangsmåde til fremstilling heraf | |
| IS7239A (is) | Aðferð til framleiðslu á essítalóprami | |
| DK1430082T3 (da) | Fremgangsmåde til syntese af insulinpolypeptid-oligomer-konjugater og proinsulinpolypeptid-oligomerkonjugater samt fremgangsmåde til syntese deraf | |
| ATE349436T1 (de) | Lipidsenkende biphenylcarbonsäureamide | |
| NO20021001D0 (no) | Radiofarmasöytiske produkter og fremstilling derav |